(Q34117457)

31 July 2017

1 reference

title

Gene expression profiling of inflammatory breast cancer (English)

1 reference

inflammatory breast cancer

31 July 2017

0 references

1 reference

3

Daniel Birnbaum

1 reference

31 July 2017

François Bertucci

1

1 reference

31 July 2017

Pascal Finetti

series ordinal

2

1 reference

31 July 2017

Patrice Viens

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

31 July 2017

1 reference

31 July 2017

116

1 reference

31 July 2017

11 Suppl

1 reference

31 July 2017

2783-2793

1 reference

Proteomics of breast cancer: principles and potential clinical applications

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Inflammatory breast cancer: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Clinically occult inflammatory carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Defining the clinical diagnosis of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Prognostic factors in inflammatory breast cancer and therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Paclitaxel in the multimodality treatment for inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Gene expression profiling and clinical outcome in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Real-time multiplex PCR assays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

WISP3 is a novel tumor suppressor gene of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

A stromal gene signature associated with inflammatory breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

MicroRNA expression profiles classify human cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Next-generation DNA sequencing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Cluster analysis and display of genome-wide expression patterns

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25165

7 January 2021

Identifiers

DOI

10.1002/CNCR.25165

1 reference

31 July 2017

1 reference